215 related articles for article (PubMed ID: 8378281)
21. [Methicillin resistance staphylococcal infections].
Matsumoto K
Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1475-80. PubMed ID: 1453072
[No Abstract] [Full Text] [Related]
22. [Typing, resistance behavior and occurrence of methicillin-resistant Staphylococcus aureus strains in a surgical intensive care unit].
Schmitz FJ; Geisel R; Wagner S; Lenz W; Kamla V; Heinz HP; Idel H; Hadding U
Zentralbl Hyg Umweltmed; 1996 Mar; 198(4):355-80. PubMed ID: 9376060
[TBL] [Abstract][Full Text] [Related]
23. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides.
Anwar MS; Bokhari SR
J Coll Physicians Surg Pak; 2003 Jan; 13(1):33-6. PubMed ID: 12685973
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
[TBL] [Abstract][Full Text] [Related]
26. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
Huang JH; Hsu RB
Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
[TBL] [Abstract][Full Text] [Related]
27. Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?
Hota B
Clin Infect Dis; 2006 Mar; 42(6):785-7. PubMed ID: 16477554
[No Abstract] [Full Text] [Related]
28. Nosocomial infection caused by methicillin-resistant Staphylococcus aureus in Palestine.
Adwan K; Abu-Hasan N; Adwan G; Jarrar N; Abu-Shanab B; Abu-Zant A
Microb Drug Resist; 2005; 11(1):75-7. PubMed ID: 15770099
[TBL] [Abstract][Full Text] [Related]
29. Glycopeptides in the treatment of staphylococcal infections.
Daschner FD; Kropec A
Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
[TBL] [Abstract][Full Text] [Related]
30. Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus.
Boyce JM; Havill NL
Am J Gastroenterol; 2005 Aug; 100(8):1828-34. PubMed ID: 16086721
[TBL] [Abstract][Full Text] [Related]
31. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
Pina P; Marliere C; Vandenesch F; Bedos JP; Etienne J; Allouch PY
Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus.
Ferrara AM
Int J Antimicrob Agents; 2007 Jul; 30(1):19-24. PubMed ID: 17475449
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of combination therapy against MRSA in Ibaraki Prefecture].
Otsuka M; Sawahata T; Nakai T; Hasegawa S; Iwata S; Yoshizawa Y; Ishida H; Irokawa M; Goto A; Shinohara Y
Jpn J Antibiot; 1994 Jun; 47(6):781-9. PubMed ID: 8072187
[TBL] [Abstract][Full Text] [Related]
34. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
Sieradzki K; Roberts RB; Haber SW; Tomasz A
N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472
[No Abstract] [Full Text] [Related]
35. Is methicillin-resistant Staphylococcus aureus involved in community acquired skin and soft tissue infections? Experience from a tertiary care centre in Mumbai.
Phakade RS; Nataraj G; Kuyare SS; Khopkar US; Mehta PR
J Postgrad Med; 2012; 58(1):3-7. PubMed ID: 22387641
[TBL] [Abstract][Full Text] [Related]
36. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
37. Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
Kono K; Takeda S; Tatara I; Arakawa K; Tanaka H; Miyake S; Minamikawa H; Hoshino H; Sato M; Hattori F
Jpn J Antibiot; 1994 Jun; 47(6):798-803. PubMed ID: 8072189
[TBL] [Abstract][Full Text] [Related]
38. Pulse-field gel electrophoresis typing of methicillin-resistant Staphylococcus aureus strains susceptible to aminoglycosides isolated from 1993 to 2002.
Lescat M; Dupeyron C; Faubert E; Mangeney N
J Hosp Infect; 2004 Jul; 57(3):253-7. PubMed ID: 15236856
[TBL] [Abstract][Full Text] [Related]
39. Vancomycin-resistant enterococcal infections.
Murray BE
N Engl J Med; 2000 Mar; 342(10):710-21. PubMed ID: 10706902
[No Abstract] [Full Text] [Related]
40. In vitro susceptibility of Staphylococcus aureus isolated from blood to currently used antistaphylococcal drugs.
Baiocchi P; Galiè M; Santini C; Carfagna P; Cassone M; Tarasi D; Venditti M
J Chemother; 1998 Feb; 10(1):25-8. PubMed ID: 9531072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
